Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Derinat helps extend hair growth by reducing harmful molecules in skin cells.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Depo-Provera effectively prevents pregnancy but has many side effects and safety concerns, leading to its ban in the U.S.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

A new delivery system makes Curcumin more effective and safer against viruses.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

The new delivery system makes retinol and niacinamide more stable and effective for anti-aging and skin-brightening.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

RU 58841 may treat acne, hair loss, and excessive hair growth.

The treatment combination is effective and generally safe for lung cancer.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Serum formulations were better at delivering molecules to the hair bulb than nanoparticles.

Ketoconazole loaded solid lipid nanoparticles can penetrate skin better than regular drug suspension and marketed product, providing slow, sustained release and improved stability.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Finasteride may help reduce impulsivity caused by pramipexole.

An injectable ibuprofen gel speeds up diabetic wound healing by reducing inflammation and promoting tissue growth.

Amlodipine impairs fertility in male rats by affecting sperm and testicular structure.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.